| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |